4.6 Article

Nanomedicines for hepatocellular carcinoma therapy: Challenges and clinical applications

期刊

MATERIALS TODAY COMMUNICATIONS
卷 34, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.mtcomm.2022.105242

关键词

Hepatocellular carcinoma; Nanomedicine; Chemotherapy; Drug delivery systems; Cancer diagnosis

向作者/读者索取更多资源

Human hepatocellular carcinoma (HCC) is a significant cause of mortality globally. Extensive research has been conducted to understand the mechanisms involved in the disease's pathogenesis and develop innovative diagnostic and therapeutic strategies. Nanotechnology has great potential in HCC diagnosis and treatment through targeted delivery, ensuring sufficient doses in tumor areas without harming normal cells.
Human hepatocellular carcinoma (HCC) has been recognized as one of the significant causes of mortality around the globe. In recent years, extensive research has been carried out to find a deep-rooted perception of mechanisms involved in the pathogenesis of the disease to develop novel strategies for compassionate diagnostic and therapeutic tools. In this regard, nanotechnology has presented great opportunities in HCC diagnosis and treatment by selective and specific targeting, and efficient delivery to reach sufficient doses in targeted tumor areas without adverse influences or minimal damage to normal cells. Herein, different Nanomedicine-mediated strategies for HCC therapy are reviewed including stem cell therapy, photodynamic and photothermal therapy, sonodynamic therapy, gene therapy, and theranostics. Also, recent developments in nanomedicine are discussed for the preparation of HCC diagnostic and drug delivery systems, and their clinical status and future perspective are highlighted.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据